COYA
Coya Therapeutics, Inc. Common Stock
NASDAQ: COYA · HEALTHCARE · BIOTECHNOLOGY
$4.07
-4.46% today
Updated 2026-04-29
Market cap
$95.47M
P/E ratio
—
P/S ratio
12.02x
EPS (TTM)
$-1.27
Dividend yield
—
52W range
$4 – $8
Volume
0.1M
Coya Therapeutics, Inc. Common Stock (COYA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | $8.75M | $4.79M | $8.40M | $41.26M | $44.35M |
| Cash & equivalents | $8.72M | $4.34M | $5.93M | $32.63M | $38.34M |
| Current assets | $8.75M | $4.58M | $7.18M | $41.20M | $44.31M |
| Total liabilities | $447121.00 | $1.15M | $16.79M | $5.63M | $4.77M |
| Current liabilities | $447121.00 | $1.15M | $3.82M | $5.05M | $3.82M |
| Long-term debt | — | — | $12.97M | — | — |
| Shareholder equity | $8.30M | $3.64M | $-8.39M | $35.64M | $39.58M |
| Retained earnings | $-731979.00 | $-5.62M | $-17.87M | $-25.86M | $-40.74M |
| Accounts receivable | $1000.00 | — | — | $7.50M | $730581.00 |
| Inventory | — | — | — | — | — |
| Goodwill | — | — | — | — | — |